AusCann (ASX:AC8) up more than 65pc after completing testing of hard-shell capsules
- Medicinal cannabis company AusCann Group (AC8) is up more than 65 per cent today after completing manufacturing and testing of its hard-shall capsules
- Once tested, the capsules were found to have met all applicable criteria set out by the Australian Therapeutic Goods Administration (TGA)
- These capsules are a unique presentation for cannabinoid medicines and a clinical evaluation will provide the best dose selection
AusCann up more than 65pc after completing testing of hard-shell capsules
Add AC8 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.62M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| AC8 (ASX) Chart |
Day chart unavailable